Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
International Seaways Inc. stock logo
INSW
International Seaways
$45.25
+1.1%
$40.66
$27.20
$54.84
$2.21B0.05592,666 shs443,097 shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$579.61
-1.3%
$555.84
$476.49
$1,210.97
$62.21B0.331.08 million shs616,549 shs
RLI Corp. stock logo
RLI
RLI
$67.63
-1.2%
$69.04
$65.14
$91.14
$6.29B0.66505,408 shs407,594 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
International Seaways Inc. stock logo
INSW
International Seaways
+1.26%+1.98%+10.02%+22.00%-10.47%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
-1.25%-3.10%+3.84%+17.51%-51.67%
RLI Corp. stock logo
RLI
RLI
-1.29%-1.16%+1.45%-12.00%-11.41%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
International Seaways Inc. stock logo
INSW
International Seaways
3.4998 of 5 stars
2.51.02.50.03.02.51.3
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4.8595 of 5 stars
4.43.01.72.33.41.71.9
RLI Corp. stock logo
RLI
RLI
4.2555 of 5 stars
2.12.03.31.82.93.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
International Seaways Inc. stock logo
INSW
International Seaways
3.00
Buy$53.5018.23% Upside
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.81
Moderate Buy$817.6741.07% Upside
RLI Corp. stock logo
RLI
RLI
2.14
Hold$78.6016.23% Upside

Current Analyst Ratings Breakdown

Latest INSW, REGN, and RLI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$753.00 ➝ $781.00
8/27/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$813.00 ➝ $831.00
8/14/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/14/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$890.00
8/11/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$940.00 ➝ $812.00
8/6/2025
International Seaways Inc. stock logo
INSW
International Seaways
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$70.00 ➝ $60.00
8/4/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$600.00 ➝ $640.00
8/4/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$688.00 ➝ $695.00
8/1/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$810.00 ➝ $815.00
8/1/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$580.00
8/1/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
International Seaways Inc. stock logo
INSW
International Seaways
$951.61M2.35$11.09 per share4.08$38.48 per share1.18
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$14.20B4.33$45.14 per share12.84$282.48 per share2.05
RLI Corp. stock logo
RLI
RLI
$1.77B3.51$2.94 per share22.98$18.89 per share3.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
International Seaways Inc. stock logo
INSW
International Seaways
$416.72M$4.819.419.73N/A29.88%11.35%8.27%11/6/2025 (Estimated)
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$4.41B$39.6814.6115.241.9631.37%15.06%11.77%10/30/2025 (Estimated)
RLI Corp. stock logo
RLI
RLI
$345.78M$3.4919.3821.81N/A17.81%15.82%4.52%10/20/2025 (Estimated)

Latest INSW, REGN, and RLI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
International Seaways Inc. stock logo
INSW
International Seaways
$0.91$1.02+$0.11$1.25$199.06 million$188.82 million
8/1/2025Q2 2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$8.43$12.89+$4.46$12.81$3.30 billion$3.68 billion
7/21/2025Q2 2025
RLI Corp. stock logo
RLI
RLI
$0.75$0.84+$0.09$1.34$445.55 million$562.28 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
International Seaways Inc. stock logo
INSW
International Seaways
$0.481.06%N/A9.98%N/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$3.520.61%N/A8.87%N/A
RLI Corp. stock logo
RLI
RLI
$0.640.95%N/A18.34%51 Years

Latest INSW, REGN, and RLI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/5/2025
International Seaways Inc. stock logo
INSW
International Seaways
quarterly$0.121.1%9/10/20259/10/20259/24/2025
8/14/2025
RLI Corp. stock logo
RLI
RLI
quarterly$0.160.95%8/29/20258/29/20259/19/2025
8/1/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
quarterly$0.880.6%8/18/20258/18/20259/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
International Seaways Inc. stock logo
INSW
International Seaways
0.14
0.95
0.95
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.09
4.60
3.72
RLI Corp. stock logo
RLI
RLI
0.06
0.35
0.35

Institutional Ownership

CompanyInstitutional Ownership
International Seaways Inc. stock logo
INSW
International Seaways
67.29%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
83.31%
RLI Corp. stock logo
RLI
RLI
77.89%

Insider Ownership

CompanyInsider Ownership
International Seaways Inc. stock logo
INSW
International Seaways
2.00%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7.02%
RLI Corp. stock logo
RLI
RLI
2.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
International Seaways Inc. stock logo
INSW
International Seaways
2,82449.37 million48.38 millionOptionable
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
15,106105.99 million98.55 millionOptionable
RLI Corp. stock logo
RLI
RLI
1,14791.83 million89.85 millionOptionable

Recent News About These Companies

Northern Trust Corp Raises Holdings in RLI Corp. $RLI
Wellington Management Group LLP Grows Stake in RLI Corp. $RLI
RLI Corp. $RLI Stake Lifted by Maren Capital LLC
Nuveen LLC Purchases New Position in RLI Corp. $RLI
RLI Corp. $RLI Shares Acquired by Bruce & Co. Inc.
RLI Corp. (NYSE:RLI) Sees Significant Growth in Short Interest

New MarketBeat Followers Over Time

Media Sentiment Over Time

International Seaways stock logo

International Seaways NYSE:INSW

$45.25 +0.51 (+1.14%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$45.00 -0.26 (-0.56%)
As of 07:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

International Seaways, Inc. owns and operates a fleet of oceangoing vessels for the transportation of crude oil and petroleum products in the international flag trade. It operates in two segments: Crude Tankers and Product Carriers. As of December 31, 2023, the company owned a fleet of 73 vessels. It serves independent and state-owned oil companies, oil traders, refinery operators, and international government entities. The company was formerly known as OSG International, Inc. and changed its name to International Seaways, Inc. in October 2016. International Seaways, Inc. was incorporated in 1999 and is headquartered in New York, New York.

Regeneron Pharmaceuticals stock logo

Regeneron Pharmaceuticals NASDAQ:REGN

$579.61 -7.35 (-1.25%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$578.25 -1.36 (-0.23%)
As of 07:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

RLI stock logo

RLI NYSE:RLI

$67.63 -0.84 (-1.23%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$67.60 -0.02 (-0.03%)
As of 08/28/2025 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RLI Corp., an insurance holding company, underwrites property and casualty insurance. Its Casualty segment provides commercial and personal coverage products; and general liability products, such as coverage for third-party liability of commercial insureds, including manufacturers, contractors, apartments, and mercantile. It also offers coverages for security guards and environmental liability for underground storage tanks, contractors and asbestos, and environmental remediation specialists; and professional liability coverages for errors and omission coverage for small to medium-sized design, technical, computer, and miscellaneous professionals. This segment provides commercial automobile liability and physical damage insurance to local, intermediate and long haul truckers, public transportation entities, and other types of specialty commercial automobile risks; incidental and related insurance coverages; inland marine coverages; management liability coverages, such as directors and officers liability insurance, fiduciary liability and coverages, employment practice liability, and for various classes of risks, including public and private businesses; and home business insurance products. The company's Property segment offers commercial property, cargo, hull, protection and indemnity, marine liability, inland marine, homeowners' and dwelling fire, and other property insurance products. Its Surety segment offers commercial surety bonds for medium to large-sized businesses; small bonds for businesses and individuals; and bonds for small to medium-sized contractors. The company also engages in various reinsurance coverages. It markets its products through branch offices, wholesale and retail brokers, carrier partners, and underwriting and independent agents. RLI Corp. was incorporated in 1965 and is headquartered in Peoria, Illinois.